Outcomes of a Novel Technique Minimal Scar Mastectomy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorKK Women's and Children's Hospital
About this trial
Nipple sparing mastectomy is oncologically safe and has a good cosmetic outcome. However, nipple sparing mastectomy was conventionally performed with reconstruction. Minimal scar mastectomy (MSM) is a novel technique which could allow women, with non-ptotic breasts, who do not want reconstruction, to conserve their nipple areolar complex (NAC) and avoid the transverse scar associated with modified radical mastectomy. This is the first study on the oncologic and surgical outcomes of MSM.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
breast cancer patients with non-ptotic breasts, who do not want reconstruction, to conserve their nipple areolar complex (NAC) and avoid the transverse scar associated with modified radical mastectomy.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
nipple sparing mastectomy without reconstruction
Procedure/Surgerynipple sparing mastectomy was conventionally performed with reconstruction. we aim to study the outcomes in the group of patients with Minimal scar mastectomy (MSM) who have nipple sparing mastectomy without reconstruction
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: nipple sparing mastectomy without reconstruction1 intervention
Trial outcomes
Primary outcomes
1
oncological outcome
recurrence rate
Time frame
5 years from operationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov